Adirondack Research & Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $628K | Sell |
90,020
-9,400
| -9% | -$65.6K | 0.76% | 56 |
|
|
2021
Q2 | $828K | Sell |
99,420
-35,611
| -26% | -$297K | 0.97% | 46 |
|
|
2021
Q1 | $737K | Buy |
135,031
+8,337
| +7% | +$45.5K | 0.87% | 53 |
|
|
2020
Q4 | $544K | Sell |
126,694
-63,800
| -33% | -$274K | 0.74% | 51 |
|
|
2020
Q3 | $573K | Hold |
190,494
| – | – | 0.8% | 45 |
|
|
2020
Q2 | $591K | Buy |
190,494
+64,252
| +51% | +$199K | 0.78% | 43 |
|
|
2020
Q1 | $279K | Sell |
126,242
-4,800
| -4% | -$10.6K | 0.39% | 61 |
|
|
2019
Q4 | $400K | Hold |
131,042
| – | – | 0.35% | 66 |
|
|
2019
Q3 | $403K | Sell |
131,042
-236,400
| -64% | -$727K | 0.35% | 70 |
|
|
2019
Q2 | $735K | Sell |
367,442
-67,565
| -16% | -$135K | 0.53% | 53 |
|
|
2019
Q1 | $1.88M | Sell |
435,007
-117,916
| -21% | -$508K | 1.17% | 30 |
|
|
2018
Q4 | $1.76M | Buy |
552,923
+63,603
| +13% | +$202K | 1.1% | 35 |
|
|
2018
Q3 | $2.57M | Buy |
489,320
+62,148
| +15% | +$326K | 0.96% | 46 |
|
|
2018
Q2 | $2.29M | Buy |
427,172
+94,680
| +28% | +$506K | 0.89% | 49 |
|
|
2018
Q1 | $1.66M | Buy |
+332,492
| New | +$1.66M | 0.67% | 59 |
|